Skip to main content

Fourth Consecutive Win For Bayer In Roundup Lawsuit

Fourth Consecutive Win For Bayer In Roundup Lawsuit

Fourth Consecutive Win For Bayer In Roundup Lawsuit

Introduction

Bayer has won the fourth consecutive trial as the jury found that the company's Roundup weedkiller did not cause cancer in the Oregon man involved in the lawsuit.

The verdict was announced in the Circuit Court of Jackson County, Oregon, after considering the assessments of expert regulators worldwide. The company even provided reports and scientific studies of over four decades which stated that the Roundup is safe for use and is not carcinogenic.

The spokesperson for the company said that it will continue to defend Roundup by standing firmly with the decision that it is safe for use.

Bayer faces a number of lawsuits against its weedkiller where all the plaintiffs allege that exposure to the product causes cancer due to the presence of Glyphosate, an active ingredient of Roundup. The lawsuits mostly involve residential gardeners who are more exposed to the weedkiller.

Bayer bought Monsanto in 2018, which is the parent manufacturer of Roundup, and the company is facing growing litigation throughout the country. Bayer has already settled 100,000 Roundup cases resulting in penalties worth billions of dollars.

The studies found that glyphosate may cause eye or skin irritation. It is also linked to causing irritation in the nose and throat if a human breathes the spray mist from the products. Increased saliva, burns in the mouth and throat, nausea, vomiting, and diarrhea are other consequences of swallowing glyphosate products.

The weedkiller is also linked to non-Hodgkin's lymphoma, but in the earlier trial, Bayer won the lawsuit due to lack of evidence. It was the third consecutive win for the company.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!